Rare diseases have kept their secrets long enough
Go beyond standard testing to uncover the mechanisms behind hard-to-diagnose conditions. With flexible, end to end workflows and real-time data, Oxford Nanopore sequencing empowers you to resolve the full spectrum of variants and methylation in one go – and bring answers to those who need them most.
Why choose Oxford Nanopore?
The most complete view of genomic variants and epigenetic modifications.
Sample-to-answer whole genome sequencing in just 24 hours.
A single, unified platform to replace multiple assays.
Compatibility with tertiary analysis and interpretation partners
)
The value that you get with a technology such as long-read sequencing really surpasses and is much more important and easier to analyse than any other data type out there.Danny Miller
University of Washington
)
PromethION 24
Combining up to 24 independently addressable, high-capacity flow cells with powerful, integrated compute, PromethION 24 delivers flexible, on-demand access to terabases of ultra-rich sequencing data — ideal for comprehensive variant identification across large numbers of clinical research samples.
)
)
New approaches for human and clinical research
In this white paper, we explore how Oxford Nanopore sequencing of native DNA and RNA overcome the limitations of short-read sequencing to deliver the most comprehensive characterisation of the human genome.
